机器学习识别射血分数保留心衰的新表型组
该研究对320例稳定性HFpEF门诊患者(56%女性,中位年龄78岁)的32项超声心动图变量和11项临床及实验室变量进行基于模型的聚类分析,识别出6个表型组。
要点
- 机器学习可识别HFpEF的6个表型组,各组临床特征和预后不同
- 表型组2患者年龄更大、舒张功能和右室功能更差、危险因素负担更高
- 表型组2中三分之一在100天内发生主要终点,三分之二在18个月内发生
核心结论
- 机器学习识别出HFpEF的6个表型组,各组临床特征、炎症和心血管蛋白水平及预后存在差异。
研究设计与样本
- 研究基于Karolinska-Rennes队列研究的320例HFpEF门诊患者(56%女性,中位年龄78岁,IQR 71-83),对32项超声心动图变量和11项临床及实验室变量进行基于模型的聚类分析。
主要发现
- 6个表型组间房颤、贫血和肾脏疾病患病率存在显著差异(p<0.05)。
- 复合终点(全因死亡或心衰住院)在表型组间差异显著(log-rank p<0.001),见于短期(100天)、中期(18个月)和长期(1000天)随访。
- 表型组2患者年龄更大,舒张功能和右室功能更差,房颤(85%)、高血压(83%)和COPD(30%)负担更高。
- 表型组2中三分之一在100天内发生主要终点,三分之二在18个月内发生;与表型组1、3、4、5、6相比的HR(95%CI)分别为1.5(0.8-2.9)、5.7(2.6-12.8)、2.9(1.5-5.6)、2.7(1.6-4.6)、2.1(1.2-3.9)。
临床怎么用
- 基于临床和超声心动图数据的机器学习表型分组有助于识别HFpEF高危亚组,表型组2预后尤其差,可能需要更密切随访。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Heart failure with preserved ejection fraction (HFpEF) is a heterogeneous syndrome. We aimed to derive HFpEF phenotype-based groups ('phenogroups') based on clinical and echocardiogram data using machine learning, and to compare clinical characteristics, proteomics and outcomes across the phenogroups. METHODS: We applied model-based clustering to 32 echocardiogram and 11 clinical and laboratory variables collected in stable condition from 320 HFpEF outpatients in the Karolinska-Rennes cohort study (56% female, median 78 years (IQR: 71-83)). Baseline proteomics and the composite end point of all-cause mortality or heart failure (HF) hospitalisation were used in secondary analyses. RESULTS: We identified six phenogroups, for which significant differences in the prevalence of concomitant atrial fibrillation (AF), anaemia and kidney disease were observed (p<0.05). Fifteen out of 86 plasma proteins differed between phenogroups (false discovery rate, FDR<0.05), including biomarkers of HF, AF and kidney function. The composite end point was significantly different between phenogroups (log-rank p<0.001), at short-term (100 days), mid-term (18 months) and longer-term follow-up (1000 days). Phenogroup 2 was older, with poorer diastolic and right ventricular function and higher burden of risk factors as AF (85%), hypertension (83%) and chronic obstructive pulmonary disease (30%). In this group a third experienced the primary outcome to 100 days, and two-thirds to 18 months (HR (95% CI) versus phenogroups 1, 3, 4, 5, 6: 1.5 (0.8-2.9); 5.7 (2.6-12.8); 2.9 (1.5-5.6); 2.7 (1.6-4.6); 2.1 (1.2-3.9)). CONCLUSIONS: Using machine learning we identified distinct HFpEF phenogroups with differential characteristics and outcomes, as well as differential levels of inflammatory and cardiovascular proteins.
引用
- Hedman ÅK, Hage C, Sharma A, et al. Identification of novel pheno-groups in heart failure with preserved ejection fraction using machine learning. Heart. 2020. PMID: 31911501. doi:10.1136/heartjnl-2019-315481
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。